Business Wire: May 24, 2017 – RESEARCH TRIANGLE PARK, NC, U.S.A. – Liquidia Technologies, Inc., today announced initial data from its LIQ865 internal clinical development program, which is a PRINT® formulation for the sustained-delivery of free base bupivacaine for postsurgical pain relief. The…
